Related Experiment Video
Updated: May 29, 2026

Comprehensive Endovascular and Open Surgical Management of Cerebral Arteriovenous Malformations
Published on: October 20, 2017
Clinical Approaches to the Diagnosis and Treatment of Vascular Anomalies
Arun K Gosain1, Parul Rai1, Emily George1
1From the Division of Plastic Surgery, Ann & Robert H. Lurie Children's Hospital of Chicago.
Insights
Vascular anomalies are classified using the International Society for the Study of Vascular Anomalies framework. Understanding molecular pathways and using targeted therapies like propranolol and sirolimus are key for effective, multidisciplinary management.
Area of Science:
- Vascular biology and medicine
- Genetics and molecular pathways
- Medical imaging and diagnostics
Background:
- Vascular anomalies present a diverse spectrum of conditions, ranging from minor birthmarks to severe, life-threatening lesions.
- Accurate classification is crucial for effective treatment, utilizing the International Society for the Study of Vascular Anomalies (ISSVA) biological framework.
- Recent advances in molecular genetics have identified key mutations driving these anomalies, paving the way for targeted therapies.
Purpose of the Study:
- To provide a comprehensive overview of vascular anomalies, integrating current knowledge on classification, pathophysiology, and management.
- To highlight the role of molecular genetics in understanding disease mechanisms and guiding targeted treatment strategies.
- To outline a systematic diagnostic and management approach for clinicians.
Main Methods:
- Classification based on the ISSVA biological framework differentiating tumors from malformations.
- Identification of key molecular pathways (e.g., PI3K/AKT/mTOR, RAS/MAPK) and driver mutations.
- Integration of clinical presentation, advanced imaging (Doppler ultrasound, MRI), and genetic testing for diagnosis.
- Review of current therapeutic modalities including pharmacologic agents (propranolol, sirolimus), laser, endovascular, and surgical interventions.
Main Results:
- Vascular anomalies are heterogeneous, requiring precise classification into tumors or malformations.
- Molecular insights have revealed critical signaling pathways implicated in their development.
- Targeted therapies, informed by genetic findings, are revolutionizing treatment approaches.
- Multidisciplinary management plans are essential for optimizing outcomes.
Conclusions:
- Effective management of vascular anomalies relies on accurate classification via the ISSVA framework.
- Understanding the molecular pathophysiology enables targeted medical therapies, such as propranolol and sirolimus.
- A coordinated, multidisciplinary team approach is vital for addressing the complexity and multisystemic nature of these conditions.
- Integrating clinical expertise with advanced diagnostics and tailored therapies improves patient outcomes.
Learning Objectives:
After studying this article, the participant should be able to: 1. Classify vascular anomalies as either proliferative tumors or structural malformations using the current International Society for the Study of Vascular Anomalies biological framework. 2. Identify key molecular pathways and somatic mutations that serve as targets for modern medical therapies. 3. Differentiate between high-flow and slow-flow malformations based on hemodynamic characteristics observed in Doppler ultrasound and magnetic resonance imaging. 4. Summarize the indications, mechanisms of action, and potential adverse effects of primary pharmacologic agents, including propranolol and sirolimus. 5. Formulate a multidisciplinary management plan that integrates medical, laser, and surgical modalities tailored to specific anomaly subtypes.
Summary:
Vascular anomalies encompass a heterogeneous group of disorders, from simple birthmarks to complex, life-threatening lesions. Effective management is predicated on the International Society for the Study of Vascular Anomalies classification, which provides a biological framework for differentiating proliferative vascular tumors from structural vascular malformations. In this article, the authors synthesize current knowledge on the epidemiology, clinical presentation, and pathophysiology of these conditions, including significant advances in molecular genetics that have identified key driver mutations in signaling pathways, such as PI3K/AKT/mTOR and RAS/MAPK. This understanding has not only refined diagnosis but also ushered in an era of targeted medical therapies. The present article outlines a systematic approach to diagnosis, combining clinical acumen with essential imaging modalities and strategic genetic testing. Current management strategies for vascular anomalies include observation, medical therapy (eg, propranolol and sirolimus), laser treatment, endovascular interventions, and resection. Given the complexity of these conditions and their multisystemic nature, a coordinated, multidisciplinary team approach is essential for optimizing patient outcomes.
Related Concept Videos
Varicose Veins II: Diagnostic Studies and Interprofessional Care
Aneurysm III: Interprofessional Care
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Overview of the Vascular System
Imaging Studies VII: Vascular Imaging
Peripheral Artery Disease III: Interprofessional Care

